In the News: Goldman Sachs-CSRC Settlement; First Sci-Tech Board Funds Approved; and Drug Administration Law Under Review
Apr 29, 2019
| By Marilyn Romero
The CSRC has agreed its first administrative settlement with Goldman Sachs and Gao Hua Securities; seven themed funds were approved for Shanghai’s new Sci-Tech Board; and the National People's Congress is reviewing measures to tighten up the production and sale of drugs.
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
This premium content is reserved for China Law & Practice Subscribers.
Unlimited access to Chinalawandpractice.com site and digital newsletters
3 free articles* across the ALM subscription network every 30 days
Exclusive discounts on ALM events and publications
Continue reading by getting started with a subscription.